The present meta-analysis investigated the grey matter abnormalities in non-CNS cancer survivals treated with chemotherapy using Anisotropic Effect Size Signed Differential Mapping (AES-SDM) according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guides. Compared with controls, the non-CNS cancer survivals treated with chemotherapy exhibit widespread grey matter abnormalities in brain, especially in prefrontal-temporal pathway, which was significantly affected by the time length since chemotherapy. This pattern of grey matter volume changes might improve our understanding of the pathophysiological nature of chemotherapy related cognitive dysfunctions.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords